Can comprehensive specialised end-of-life care be provided at home? Lessons from a study of an innovative consultant-led community service in the UK

B. Noble, N. King, A. Woolmore, P. Hughes, M. Winslow, J. Melvin, J. Brooks, A. Bravington, C. Ingleton, P. A. Bath

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The Midhurst Macmillan Specialist Palliative Care Service (MMSPCS) is a UK, medical consultant-led, multidisciplinary team aiming to provide round-the-clock advice and care, including specialist interventions, in the home, community hospitals and care homes. Of 389 referrals in 2010/11, about 85% were for cancer, from a population of about 155000. Using a mixed method approach, the evaluation comprised: a retrospective analysis of secondary-care use in the last year of life; financial evaluation of the MMSPCS using an Activity Based Costing approach; qualitative interviews with patients, carers, health and social care staff and MMSPCS staff and volunteers; a postal survey of General Practices; and a postal survey of bereaved caregivers using the MMSPCS. The mean cost is about 3000GBP (3461EUR) per patient with mean cost of interventions for cancer patients in the last year of life 1900GBP (2192EUR). Post-referral, overall costs to the system are similar for MMSPCS and hospice-led models; however, earlier referral avoided around 20% of total costs in the last year of life. Patients and carers reported positive experiences of support, linked to the flexible way the service worked. Seventy-one per cent of patients died at home. This model may have application elsewhere.

Original languageEnglish
Pages (from-to)253-266
Number of pages14
JournalEuropean Journal of Cancer Care
Volume24
Issue number2
DOIs
Publication statusPublished - 1 Mar 2015

Fingerprint

Terminal Care
Social Welfare
Consultants
Palliative Care
Caregivers
Costs and Cost Analysis
Referral and Consultation
Secondary Care
Hospices
Community Hospital
Home Care Services
General Practice
Volunteers
Neoplasms
Interviews
Delivery of Health Care
Population

Cite this

Noble, B. ; King, N. ; Woolmore, A. ; Hughes, P. ; Winslow, M. ; Melvin, J. ; Brooks, J. ; Bravington, A. ; Ingleton, C. ; Bath, P. A. / Can comprehensive specialised end-of-life care be provided at home? Lessons from a study of an innovative consultant-led community service in the UK. In: European Journal of Cancer Care. 2015 ; Vol. 24, No. 2. pp. 253-266.
@article{fa0c997bc48a46728abb359bfe73cf4b,
title = "Can comprehensive specialised end-of-life care be provided at home? Lessons from a study of an innovative consultant-led community service in the UK",
abstract = "The Midhurst Macmillan Specialist Palliative Care Service (MMSPCS) is a UK, medical consultant-led, multidisciplinary team aiming to provide round-the-clock advice and care, including specialist interventions, in the home, community hospitals and care homes. Of 389 referrals in 2010/11, about 85{\%} were for cancer, from a population of about 155000. Using a mixed method approach, the evaluation comprised: a retrospective analysis of secondary-care use in the last year of life; financial evaluation of the MMSPCS using an Activity Based Costing approach; qualitative interviews with patients, carers, health and social care staff and MMSPCS staff and volunteers; a postal survey of General Practices; and a postal survey of bereaved caregivers using the MMSPCS. The mean cost is about 3000GBP (3461EUR) per patient with mean cost of interventions for cancer patients in the last year of life 1900GBP (2192EUR). Post-referral, overall costs to the system are similar for MMSPCS and hospice-led models; however, earlier referral avoided around 20{\%} of total costs in the last year of life. Patients and carers reported positive experiences of support, linked to the flexible way the service worked. Seventy-one per cent of patients died at home. This model may have application elsewhere.",
keywords = "End-of-life care, Home care services, Home death, Mixed methods evaluation, Preferred place of care/death, Specialist palliative care",
author = "B. Noble and N. King and A. Woolmore and P. Hughes and M. Winslow and J. Melvin and J. Brooks and A. Bravington and C. Ingleton and Bath, {P. A.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1111/ecc.12195",
language = "English",
volume = "24",
pages = "253--266",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "Wiley-Blackwell",
number = "2",

}

Can comprehensive specialised end-of-life care be provided at home? Lessons from a study of an innovative consultant-led community service in the UK. / Noble, B.; King, N.; Woolmore, A.; Hughes, P.; Winslow, M.; Melvin, J.; Brooks, J.; Bravington, A.; Ingleton, C.; Bath, P. A.

In: European Journal of Cancer Care, Vol. 24, No. 2, 01.03.2015, p. 253-266.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Can comprehensive specialised end-of-life care be provided at home? Lessons from a study of an innovative consultant-led community service in the UK

AU - Noble, B.

AU - King, N.

AU - Woolmore, A.

AU - Hughes, P.

AU - Winslow, M.

AU - Melvin, J.

AU - Brooks, J.

AU - Bravington, A.

AU - Ingleton, C.

AU - Bath, P. A.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - The Midhurst Macmillan Specialist Palliative Care Service (MMSPCS) is a UK, medical consultant-led, multidisciplinary team aiming to provide round-the-clock advice and care, including specialist interventions, in the home, community hospitals and care homes. Of 389 referrals in 2010/11, about 85% were for cancer, from a population of about 155000. Using a mixed method approach, the evaluation comprised: a retrospective analysis of secondary-care use in the last year of life; financial evaluation of the MMSPCS using an Activity Based Costing approach; qualitative interviews with patients, carers, health and social care staff and MMSPCS staff and volunteers; a postal survey of General Practices; and a postal survey of bereaved caregivers using the MMSPCS. The mean cost is about 3000GBP (3461EUR) per patient with mean cost of interventions for cancer patients in the last year of life 1900GBP (2192EUR). Post-referral, overall costs to the system are similar for MMSPCS and hospice-led models; however, earlier referral avoided around 20% of total costs in the last year of life. Patients and carers reported positive experiences of support, linked to the flexible way the service worked. Seventy-one per cent of patients died at home. This model may have application elsewhere.

AB - The Midhurst Macmillan Specialist Palliative Care Service (MMSPCS) is a UK, medical consultant-led, multidisciplinary team aiming to provide round-the-clock advice and care, including specialist interventions, in the home, community hospitals and care homes. Of 389 referrals in 2010/11, about 85% were for cancer, from a population of about 155000. Using a mixed method approach, the evaluation comprised: a retrospective analysis of secondary-care use in the last year of life; financial evaluation of the MMSPCS using an Activity Based Costing approach; qualitative interviews with patients, carers, health and social care staff and MMSPCS staff and volunteers; a postal survey of General Practices; and a postal survey of bereaved caregivers using the MMSPCS. The mean cost is about 3000GBP (3461EUR) per patient with mean cost of interventions for cancer patients in the last year of life 1900GBP (2192EUR). Post-referral, overall costs to the system are similar for MMSPCS and hospice-led models; however, earlier referral avoided around 20% of total costs in the last year of life. Patients and carers reported positive experiences of support, linked to the flexible way the service worked. Seventy-one per cent of patients died at home. This model may have application elsewhere.

KW - End-of-life care

KW - Home care services

KW - Home death

KW - Mixed methods evaluation

KW - Preferred place of care/death

KW - Specialist palliative care

UR - http://www.scopus.com/inward/record.url?scp=84923300021&partnerID=8YFLogxK

U2 - 10.1111/ecc.12195

DO - 10.1111/ecc.12195

M3 - Article

VL - 24

SP - 253

EP - 266

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

IS - 2

ER -